|
PLX Protalix Biotherapeutics Inc 1006281 |
| Balance Sheet |
|
Current Assets
|
$92,220,000.00 |
|
Assets
|
$110,336,000.00 |
|
Current Liabilities
|
$31,391,000.00 |
|
Liabilities
|
$38,932,000.00 |
|
Equity
|
$71,404,000.00 |
|
Shares Out
|
80425981.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$11,625,000.00 |
|
Investing Cash Flow
|
$588,000.00 |
| Market Analysis |
Market Cap
|
$191,413,834.78 |
|
Price
|
$2.38 |
|
BVPS
|
0.89 |
|
PB
|
2.67 |
|
EPS
|
0.05 |
|
PE
|
12.60 |
|
PS
|
2.41 |
|
FCF
|
$10,271,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-18 |
-0.08 |
|
|
2026-05-13 |
0.22 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
0.00 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
0.03 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PLX documents filed with the SEC.
PLX Filings
Clear
